Neogen Corporation (NEOG)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $2.45B
Last updated: Nov 17, 2026 at 11:06 AM ET
Neogen Corporation (NEOG) Financials: Revenue, Profit and Cash Flow
Neogen reported revenue of $870.40M for the fiscal year ended May 31, 2026, down 2.7% from the year before. That year, net income was -$7.90M with a net margin of -0.9%, operating cash flow was $83.20M and free cash flow was $31.90M. The quarter ended Aug 31, 2026 had revenue of $222.80M and net income of -$11.90M.
Revenue and Margins
The operating margin was -2.5% in the fiscal year ended May 2026, the lowest of the 9 years shown with an operating margin. Over the 9 years to May 2026, revenue grew from $358.28M, a compound annual rate of 10.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| May 2026 | $870.40M | -2.7% | 46.9% | -2.5% | -0.9% |
| May 2025 | $894.70M | -3.2% | 47.1% | -118.6% | -122.1% |
| May 2024 | $924.20M | +12.4% | 50.2% | 6.3% | -1.0% |
| May 2023 | $822.45M | +56.0% | 49.4% | 4.6% | -2.8% |
| May 2022 | $527.16M | +12.5% | 46.1% | 11.1% | 9.2% |
| May 2021 | $468.46M | +12.0% | 45.9% | 15.8% | 13.0% |
| May 2020 | $418.17M | +1.0% | 46.9% | 16.1% | 14.2% |
| May 2019 | $414.19M | +4.1% | 46.3% | 16.4% | 14.5% |
| May 2018 | $397.93M | +11.1% | 46.8% | 17.6% | 15.9% |
| May 2017 | $358.28M | N/A | 47.1% | 18.1% | 12.3% |
Income Statement
In the fiscal year ended May 2026, the net loss narrowed from the year before. In the quarter ended Aug 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $870.40M | $894.70M | $924.20M | $822.45M | $527.16M | $468.46M | $418.17M | $414.19M | $397.93M | $358.28M |
| Cost of revenue | $461.90M | $473.30M | $460.30M | $416.49M | $284.15M | $253.40M | $221.89M | $222.27M | $211.66M | $189.35M |
| Gross profit | $408.50M | $421.40M | $463.90M | $405.95M | $243.01M | $215.06M | $196.28M | $191.92M | $186.27M | $168.92M |
| Research and development | $18.40M | $21.10M | $22.50M | $26.04M | $17.05M | $16.25M | $14.75M | $12.80M | $10.86M | $10.38M |
| Operating income | -$21.60M | -$1.06B | $58.60M | $37.52M | $58.62M | $74.17M | $67.52M | $68.09M | $70.19M | $64.94M |
| Net income | -$7.90M | -$1.09B | -$9.40M | -$22.87M | $48.31M | $60.88M | $59.48M | $60.18M | $63.22M | $43.97M |
| EBITDA | $172.50M | -$935.70M | $177.30M | $123.95M | $83.07M | $94.69M | $84.71M | $85.75M | $88.33M | $80.36M |
Quarterly
| Line item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $222.80M | $225.32M | $211.20M | $224.69M | $209.20M | $225.48M | $221.00M | $231.26M | $216.96M | $236.79M | $228.81M | $229.63M |
| Gross profit | $105.50M | $107.85M | $99.00M | $106.68M | $95.00M | $92.84M | $110.30M | $113.33M | $104.93M | $113.48M | $116.88M | $116.77M |
| Operating income | -$1.80M | $3.17M | -$3.30M | -$5.38M | -$16.10M | -$611.17M | $5.40M | -$457.48M | $2.26M | $13.04M | $12.02M | $14.46M |
| Net income | -$11.90M | -$11.31M | -$17.00M | -$15.92M | $36.30M | -$612.21M | -$10.90M | -$456.28M | -$12.61M | -$5.42M | -$2.02M | -$3.49M |
Balance Sheet
As of May 2026, total debt of $793.70M exceeded cash and equivalents by $608.20M.
Annual
| Line item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.35B | $3.44B | $4.55B | $4.55B | $992.93M | $920.19M | $797.18M | $695.74M | $618.01M | $528.41M |
| Current assets | $604.60M | $576.90M | $589.23M | $585.93M | $626.80M | $591.45M | $537.41M | $449.53M | $375.79M | $292.96M |
| Cash and equivalents | $185.50M | $129.00M | $170.61M | $163.24M | $44.47M | $75.60M | $66.27M | $41.69M | $83.07M | $77.57M |
| Total liabilities | $1.25B | $1.37B | $1.40B | $1.42B | $105.56M | $79.81M | $72.00M | $57.84M | $57.83M | $56.65M |
| Short-term debt | $0 | $19.30M | $2.45M | $6.55M | $2.88M | $1.28M | $1.05M | N/A | N/A | N/A |
| Long-term debt | $793.70M | $874.80M | $888.39M | $885.44M | $0 | N/A | N/A | N/A | $0 | $0 |
| Shareholder equity | $2.09B | $2.07B | $3.14B | $3.13B | $887.37M | $840.38M | $725.18M | $637.90M | $560.17M | $471.61M |
Quarterly
| Line item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.30B | $3.35B | $3.36B | $3.36B | $3.38B | $3.44B | $4.04B | $4.05B | $4.50B | $4.58B | $4.58B | $4.60B |
| Total liabilities | $1.22B | $1.25B | $1.26B | $1.26B | $1.26B | $1.37B | $1.38B | $1.39B | $1.37B | $1.44B | $1.44B | $1.45B |
| Cash and equivalents | $172.00M | $185.50M | $159.90M | $145.34M | $138.88M | $129.00M | $127.70M | $140.23M | $120.48M | $170.61M | $161.44M | $205.76M |
| Shareholder equity | $2.09B | $2.09B | $2.10B | $2.10B | $2.12B | $2.07B | $2.66B | $2.67B | $3.14B | $3.14B | $3.15B | $3.15B |
Cash Flow
In the fiscal year ended May 2026, free cash flow was 38.3% of operating cash flow.
Annual
| Line item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $83.20M | $58.20M | $35.30M | $41.03M | $68.04M | $81.09M | $85.88M | $63.84M | $69.13M | $60.27M |
| Capital expenditures | $51.30M | $104.60M | $111.40M | $65.76M | $24.43M | $26.71M | $24.05M | $14.66M | $20.95M | $14.58M |
| Free cash flow | $31.90M | -$46.40M | -$76.10M | -$24.73M | $43.61M | $54.38M | $61.83M | $49.18M | $48.19M | $45.70M |
| Share repurchases | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $3.13M | $0 | $0 |
| Investing cash flow | $70.50M | -$99.20M | -$29.30M | $201.04M | -$97.23M | -$105.56M | -$88.78M | -$119.15M | -$83.08M | -$62.14M |
| Financing cash flow | -$99.40M | -$1.60M | $1.90M | -$118.08M | $6.81M | $33.54M | $29.41M | $13.90M | $22.84M | $25.07M |
Quarterly
| Line item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $12.90M | $30.20M | $22.70M | $19.44M | $10.80M | $16.40M | $19.46M | $40.25M | -$17.91M | $26.78M | -$30.21M | $15.71M |
| Capital expenditures | $8.20M | $4.00M | $11.63M | $11.67M | $24.00M | $16.10M | $32.91M | $17.16M | $38.43M | $24.23M | $32.12M | $24.42M |
| Free cash flow | $4.70M | $26.20M | $11.07M | $7.78M | -$13.20M | $300.00K | -$13.45M | $23.10M | -$56.35M | $2.55M | -$62.33M | -$8.70M |
Frequently Asked Questions About NEOG
What is Neogen's annual revenue?
Neogen reported revenue of $870.40M for the fiscal year ended May 31, 2026.
How fast is Neogen's revenue growing?
Revenue was down 2.7% for the fiscal year ended May 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 1.9%.
Is Neogen profitable?
No. Neogen reported net income of -$7.90M for the fiscal year ended May 31, 2026, with a net margin of -0.9%.
How much free cash flow does NEOG generate?
For the fiscal year ended May 31, 2026, operating cash flow of $83.20M minus capital expenditures of $51.30M produced free cash flow of $31.90M.
How much debt does Neogen have?
The balance sheet dated May 31, 2026 reported long-term debt of $793.70M, short-term debt of $0 and cash and equivalents of $185.50M.
NEOG pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts